Beta Bionics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	38.49	30.43	26.57	27.68
Short-Term Investments	190.2	73.14	70.18	-
Cash & Short-Term Investments	228.69	103.58	96.75	27.68
Cash Growth	275.53%	7.06%	249.58%	-
Receivables	14.25	12	4.45	-
Inventory	20.37	13.32	1.25	-
Prepaid Expenses	6.45	2.98	0.91	0.54
Other Current Assets	0.27	1.05	0.28	0.25
Total Current Assets	270.03	132.92	103.62	28.47
Property, Plant & Equipment	14.41	11.42	6.2	6.87
Long-Term Deferred Charges	-	5.05	-	-
Other Long-Term Assets	0.28	0.25	0.22	0.19
Total Assets	330.05	149.65	110.04	35.53
Accounts Payable	4.46	2.85	1.17	0.43
Accrued Expenses	14.39	13.33	7.07	6.14
Current Portion of Leases	1.98	1.53	1.22	0.98
Current Unearned Revenue	1.34	0.94	0.09	-
Other Current Liabilities	3.22	2.5	1.05	1.32
Total Current Liabilities	25.39	21.15	10.61	8.87
Long-Term Leases	5.71	5.73	3	3.16
Long-Term Unearned Revenue	2.99	1.86	0.26	-
Other Long-Term Liabilities	1.21	44.9	37.57	10.5
Total Liabilities	35.29	73.63	51.43	22.53
Common Stock	0	0	0	0
Additional Paid-In Capital	650.87	51.31	26.42	15.53
Retained Earnings	-356.47	-296.74	-229.66	-185.57
Comprehensive Income & Other	0.35	0.07	0.14	-
Total Common Equity	294.76	-245.36	-203.11	-170.03
Shareholders' Equity	294.76	76.01	58.61	13
Total Liabilities & Equity	330.05	149.65	110.04	35.53
Total Debt	7.69	7.26	4.22	4.13
Net Cash (Debt)	221	96.32	92.52	23.54
Net Cash Growth	312.34%	4.11%	293.01%	-
Net Cash Per Share	7.10	15.13	17.44	4.71
Filing Date Shares Outstanding	44.02	43.35	5.03	5
Total Common Shares Outstanding	43.99	6.67	5.03	5
Working Capital	244.64	111.78	93.02	19.59
Book Value Per Share	6.70	-36.80	-40.39	-34.02
Tangible Book Value	294.76	-245.36	-203.11	-170.03
Tangible Book Value Per Share	6.70	-36.80	-40.39	-34.02
Machinery	9.49	7.48	5.78	5.56
Construction In Progress	3.35	1.74	0.17	0.18
Leasehold Improvements	0.83	0.81	0.95	0.95

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q